
GenomeKey uses genomic technology and AI to address healthcare challenges. It combines DNA sequencing with machine learning to drive targeted therapies. The approach aims to shorten time to appropriate treatment from days to hours. The company operates in the healthcare tech space, leveraging ML and sequencing as core tech. The market opportunity includes rapid, precision treatment in critical care settings.

GenomeKey uses genomic technology and AI to address healthcare challenges. It combines DNA sequencing with machine learning to drive targeted therapies. The approach aims to shorten time to appropriate treatment from days to hours. The company operates in the healthcare tech space, leveraging ML and sequencing as core tech. The market opportunity includes rapid, precision treatment in critical care settings.